Clinical trial
DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
NCT06657833 is registered in ClinicalTrials.gov with Fundación EPIC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
- Lead sponsor
- Fundación EPIC
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 17, 2024
- Completion date
- October 30, 2027
- Enrollment
- 128 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.